Literature DB >> 19128276

Gingival hyperplasia in a patient with hypertension.

A H Tajani1, Shawna D Nesbitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19128276      PMCID： PMC8673388          DOI： 10.1111/j.1751-7176.2008.00036.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  10 in total

Review 1.  Treatment of drug-induced gingival enlargement: aesthetic and functional considerations.

Authors:  P M Camargo; P R Melnick; F Q Pirih; R Lagos; H H Takei
Journal:  Periodontol 2000       Date:  2001       Impact factor: 7.589

2.  Amlodipine induced gingival hyperplasia: a rare entity.

Authors:  Vineet Bhatia; Ajay Mittal; Ashok K Parida; Rajesh Talwar; Upendra Kaul
Journal:  Int J Cardiol       Date:  2007-02-01       Impact factor: 4.164

3.  MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.

Authors:  Peter Meisel; Jürgen Giebel; Christiane Kunert-Keil; Peter Dazert; Heyo K Kroemer; Thomas Kocher
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors:  M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

6.  Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.

Authors:  P Westbrook; E M Bednarczyk; M Carlson; H Sheehan; N F Bissada
Journal:  J Periodontol       Date:  1997-07       Impact factor: 6.993

Review 7.  Amlodipine-induced gingival hyperplasia.

Authors:  Ardeshir Lafzi; Ramin Mostofi Zadeh Farahani; Mohammad Ali Mohajjel Shoja
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2006-11-01

8.  Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

Authors:  Beatrice A Golomb; John J McGraw; Marcella A Evans; Joel E Dimsdale
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Strategies for enhancing patient compliance.

Authors:  M H Becker; L A Maiman
Journal:  J Community Health       Date:  1980

Review 10.  Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis.

Authors:  M Harel-Raviv; M Eckler; K Lalani; E Raviv; M Gornitsky
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1995-06
  10 in total
  4 in total

1.  Co2 laser treatment of drug-induced gingival overgrowth - case report -.

Authors:  Carlo Fornaini; Jean Paul Rocca
Journal:  Laser Ther       Date:  2012-03-28

2.  Gingival hyperplasia and calcium channel blockers.

Authors:  Costas Fourtounas; Jannis G Vlachojannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-02       Impact factor: 3.738

Review 3.  HIV-Associated Systemic Sclerosis: Literature Review and a Rare Case Report.

Authors:  Shamimul Hasan; Mohd Aqil; Rajat Panigrahi
Journal:  Int J Environ Res Public Health       Date:  2022-08-15       Impact factor: 4.614

Review 4.  Drug-induced gingival overgrowth: A critical insight into case reports from over two decades.

Authors:  Pramod Samudrala; Vijay Kumar Chava; Tanguturi Sri Chandana; Rachakonda Suresh
Journal:  J Indian Soc Periodontol       Date:  2016 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.